- Home
- LTRN
LTRN
Lantern Pharma Inc.
as 07-26-2024 4:00pm EST
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 48.4M | IPO Year: | 2020 |
| Target Price: | $11.00 | AVG Volume (30 days): | 51.4K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.38 - $11.99 | Next Earning Date: | 08-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Lantern Pharma Inc. (LTRN)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fletcher Aaron G.L. | LTRN | 10% Owner | May 23 '24 | Sell | $6.33 | 4,253 | $26,921.49 | 131,453 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | May 23 '24 | Sell | $6.25 | 2,126 | $13,287.50 | 135,706 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | May 23 '24 | Sell | $6.33 | 13,888 | $87,911.04 | 429,286 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | May 23 '24 | Sell | $6.25 | 6,944 | $43,400.00 | 443,174 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | May 23 '24 | Sell | $6.33 | 1,859 | $11,767.47 | 57,467 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | May 23 '24 | Sell | $6.25 | 930 | $5,812.50 | 59,326 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | May 23 '24 | Sell | $6.25 | 930 | $5,812.50 | 59,326 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | May 23 '24 | Sell | $6.33 | 1,859 | $11,767.47 | 57,467 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | May 23 '24 | Sell | $6.25 | 6,944 | $43,400.00 | 443,174 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | May 23 '24 | Sell | $6.33 | 13,888 | $87,911.04 | 429,286 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | May 23 '24 | Sell | $6.25 | 2,126 | $13,287.50 | 135,706 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | May 23 '24 | Sell | $6.33 | 4,253 | $26,921.49 | 131,453 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.87 | 4,185 | $20,380.95 | 137,832 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.85 | 15,780 | $76,533.00 | 142,017 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.40 | 10,620 | $46,728.00 | 157,797 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.87 | 13,686 | $66,650.82 | 450,118 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.85 | 51,608 | $250,298.80 | 463,804 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.40 | 34,731 | $152,816.40 | 515,412 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.87 | 1,832 | $8,921.84 | 60,256 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.85 | 6,909 | $33,508.65 | 62,088 | SEC Form 4 |
| Fletcher Aaron G.L. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.40 | 4,649 | $20,455.60 | 68,997 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.40 | 4,649 | $20,455.60 | 68,997 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.85 | 6,909 | $33,508.65 | 62,088 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.87 | 1,832 | $8,921.84 | 60,256 | SEC Form 4 |
| Kreis Leslie W. | LTRN | 10% Owner | Feb 27 '24 | Sell | $4.40 | 34,731 | $152,816.40 | 515,412 | SEC Form 4 |
Latest Lantern Pharma Inc. News
LTRN Breaking Stock News: Dive into LTRN Ticker-Specific Updates for Smart Investing
Simply Wall St.
11 days ago
We're Not Very Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Rate
Business Wire
17 days ago
Lantern Pharma Achieves Key Milestone Towards Development of Molecular Diagnostic for use in Oncology Clinical Trials for Patient Selection and Stratification with Drug Candidate LP-184
MT Newswires
a month ago
Lantern Pharma Secures Composition of Matter Patent for LP-284 in Japan
Business Wire
a month ago
Lantern Pharma Receives Certificate of Patent from Japanese Patent Office (JPO) for Composition of Matter Covering Drug Candidate LP-284
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Simply Wall St.
2 months ago
Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
Simply Wall St.
2 months ago
Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
Compare LTRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LTRN Lantern Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.